Search research articles
Contact Us
Filters
Showing results (401-410 of 522) with videos related to
Page
of 53
Sort By:
The New England Journal of Medicine
|
September 1, 2025
Aspirin in Patients with Chronic Coronary Syndrome Receiving Oral Anticoagulation
Gilles Lemesle, Romain Didier, Philippe Gabriel Steg, et al.
European Journal of Internal Medicine
|
May 22, 2019
Hereditary angioedema, emergency management of attacks by a call center
Nicolas Javaud, Adrien Altar, Olivier Fain, et al.
Journal of Hepatology
|
August 10, 2013
ESM-1 expression in stromal cells is predictive of recurrence after radiofrequency ablation in early hepatocellular carcinoma
Marianne Ziol, Angela Sutton, Julien Calderaro, et al.
Trials
|
May 4, 2016
Dedicated call center (SOS-HAE) for hereditary angioedema attacks: study protocol for a randomised controlled trial
Nicolas Javaud, Olivier Fain, Isabelle Durand-Zaleski, et al.
Cerebrovascular Diseases (Basel, Switzerland)
|
January 16, 2017
The Intracranial-B2LEED3S Score and the Risk of Intracranial Hemorrhage in Ischemic Stroke Patients Under Antiplatelet Treatment
Pierre Amarenco, Leila Sissani, Julien Labreuche, et al.
European Journal of Preventive Cardiology
|
November 7, 2024
Defective biological activities of high-density lipoprotein identify patients at highest risk of recurrent cardiovascular event
Johanne Silvain, Clément Materne, Michel Zeitouni, et al.
Therapie
|
July 10, 2016
[Not Available]
Jean-François Dhainaut, François Bassompierre, Christophe Misse, et al.
Circulation. Cardiovascular Interventions
|
March 16, 2019
Risk-Benefit Profile of Longer-Than-1-Year Dual-Antiplatelet Therapy Duration After Drug-Eluting Stent Implantation in Relation to Clinical Presentation
Tullio Palmerini, Antonio G Bruno, Martine Gilard, et al.
The American Journal of Cardiology
|
September 10, 2013
A direct comparison of intravenous enoxaparin with unfractionated heparin in primary percutaneous coronary intervention (from the ATOLL trial)
Jean-Philippe Collet, Kurt Huber, Marc Cohen, et al.
Open Forum Infectious Diseases
|
January 8, 2020
Benefits of Polymerase Chain Reaction Combined With Culture for the Diagnosis of Bone and Joint Infections: A Prospective Test Performance Study
Hervé Jacquier, Vincent Fihman, Rishma Amarsy, et al.
Page
of 53
Search research articles
Search
Showing results (401-410 of 522) with videos related to
Sort By:
Page
of 53
The New England Journal of Medicine
|
September 1, 2025
Aspirin in Patients with Chronic Coronary Syndrome Receiving Oral Anticoagulation
Gilles Lemesle, Romain Didier, Philippe Gabriel Steg, et al.
European Journal of Internal Medicine
|
May 22, 2019
Hereditary angioedema, emergency management of attacks by a call center
Nicolas Javaud, Adrien Altar, Olivier Fain, et al.
Journal of Hepatology
|
August 10, 2013
ESM-1 expression in stromal cells is predictive of recurrence after radiofrequency ablation in early hepatocellular carcinoma
Marianne Ziol, Angela Sutton, Julien Calderaro, et al.
Trials
|
May 4, 2016
Dedicated call center (SOS-HAE) for hereditary angioedema attacks: study protocol for a randomised controlled trial
Nicolas Javaud, Olivier Fain, Isabelle Durand-Zaleski, et al.
Cerebrovascular Diseases (Basel, Switzerland)
|
January 16, 2017
The Intracranial-B2LEED3S Score and the Risk of Intracranial Hemorrhage in Ischemic Stroke Patients Under Antiplatelet Treatment
Pierre Amarenco, Leila Sissani, Julien Labreuche, et al.
European Journal of Preventive Cardiology
|
November 7, 2024
Defective biological activities of high-density lipoprotein identify patients at highest risk of recurrent cardiovascular event
Johanne Silvain, Clément Materne, Michel Zeitouni, et al.
Therapie
|
July 10, 2016
[Not Available]
Jean-François Dhainaut, François Bassompierre, Christophe Misse, et al.
Circulation. Cardiovascular Interventions
|
March 16, 2019
Risk-Benefit Profile of Longer-Than-1-Year Dual-Antiplatelet Therapy Duration After Drug-Eluting Stent Implantation in Relation to Clinical Presentation
Tullio Palmerini, Antonio G Bruno, Martine Gilard, et al.
The American Journal of Cardiology
|
September 10, 2013
A direct comparison of intravenous enoxaparin with unfractionated heparin in primary percutaneous coronary intervention (from the ATOLL trial)
Jean-Philippe Collet, Kurt Huber, Marc Cohen, et al.
Open Forum Infectious Diseases
|
January 8, 2020
Benefits of Polymerase Chain Reaction Combined With Culture for the Diagnosis of Bone and Joint Infections: A Prospective Test Performance Study
Hervé Jacquier, Vincent Fihman, Rishma Amarsy, et al.
Page
of 53